Paris, France

Serge Maitrejean

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 569(Granted Patents)


Company Filing History:


Years Active: 1991-2025

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Unveiling the Innovation Journey of Inventor Serge Maitrejean

Introduction:

Serge Maitrejean, a brilliant inventor based in Paris, FR, has made a significant impact in the field of medical diagnostics and imaging. With a remarkable portfolio of 11 patents, his contributions have paved the way for cutting-edge advancements in in vivo optical imaging technologies.

Latest Patents:

Maitrejean's latest patents revolve around the use of persistent luminescence nanoparticles as a diagnostic agent for in vivo optical imaging. These nanoparticles, made of specific compounds such as silicates, aluminates, and metal oxides doped with rare earth ions, play a vital role in organism vascularization imaging. Additionally, his inventions include a method and kit for detecting substances of biological or chemical interest in samples using pre-functionalized nanoparticles.

Career Highlights:

Having worked with companies like Europ Scan and Biospace Instruments, Maitrejean has honed his expertise in the intersection of nanotechnology and medical imaging. His innovative solutions have garnered recognition for their potential to revolutionize the field of diagnostic imaging and improve patient outcomes.

Collaborations:

Throughout his career, Maitrejean has collaborated with accomplished professionals in the industry. Notable coworkers such as Didier Perion and Pascal DeSaute have contributed to the success of his projects, showcasing the power of teamwork in driving innovation forward.

Conclusion:

Inventor Serge Maitrejean's dedication to pushing the boundaries of medical diagnostics through his groundbreaking patents is truly commendable. His inventive spirit and collaborative mindset continue to inspire advancements in the field, shaping the future of in vivo optical imaging technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…